Binding and Internalization of Herpes Simplex Virus-Antibody Complexes by Polymorphonuclear Leukocytes by Smith, Jerry W. et al.
Journal of Medical Virology 20:151-163 (1986) 
Binding and Internalization of Herpes 
Simplex Vi rus-Ant i body Complexes by 
Polymorphonuclear Leukocytes 
Jerry W. Smith, James R. Jachimowicz, and Eve L. Bingham 
Department of Ophthalmology, University of Michigan, Ann Arbor, Michigan 
(J. W S., E. L. B.); Difco Laboratories, Detroit, Michigan (J. W S.); Department of 
Microbiology and Immunology, Louisiana State University, New Orleans, 
Louisiana (J. R. J.) 
We studied the interactions between rabbit polymorphonuclear leukocytes (PMN) 
and the RE strain of herpes simplex virus type 1 (HSV-1) to determine better the 
role of inflammatory cells in herpetic stromal keratitis. PMN were found to be 
nonpermissive for HSV replication and were unable to bind virus in the absence 
of antibody. However, PMN did bind and internalize HSV-antibody complexes in 
vitro as was demonstrated visually by electron microscopic studies and quantita- 
tively by measurement of activity associated with radiolabeled HSV-antibody 
complexes. Virus used for immune complex formation was labeled with either 
12’Iodine or 35S-methionine. In some experiments, anti-HSV IgG used for immune 
complex formation was labeled with 12’Iodine before incubation with virus. Use 
of all three radiolabeling approaches resulted in the same general pattern of 
binding, indicating a requirement for both antibody and virus for interaction with 
PMN. The activity associated with PMN was increased by preincubation with 
complement. The results suggest an active role for PMN in controlling HSV 
infection through their ability to bind and ingest virus-antibody complexes. 
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INTRODUCTION 
Traditionally, the most important cells involved in antiviral immunity have been 
thought to be those comprising the lymphocyte-macrophage defense system. Al- 
though polymorphonuclear leukocytes (PMN) have been shown to function as primary 
effector cells in acute inflammatory responses to bacterial and mycotic infections, 
there is increasing evidence to suggest PMN play an important role in antiviral 
defense. 
PMN have been observed in the inflammatory infiltrates in specific infections; 
for example, the cerebrospinal fluid of children with viral meningitis [Feigin and 
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Shakelford, 19731 and the cutaneous lesions of varicella zoster infections [Stevens et 
al, 19751. In herpetic stromal keratitis, a disease characterized by corneal opacity and 
scarring, an infiltrate consisting mainly of PMN and macrophages persists in the 
limbus and later the cornea for 4-5 days postinfection [Metcalf and Reichert, 19791. 
A possible role for PMN in lower respiratory tract infections caused by respi- 
ratory syncytial virus (RSV) has been suggested by demonstrating in vitro activation 
of oxidative and arachidonic acid metabolism of PMN with RSV immune complexes 
[Kaul et al, 1981; Faden et al, 19831. 
Although interactions that occur between host phagocytes and herpes simplex 
virus (HSV) during infection have not been extensively investigated, it has been 
assumed that the known mechanisms of antimicrobial immunity mediated by PMN 
participate in the activation and clearance of virus and virus-antibody complexes 
[Notkins et al, 1970; Theofilopoulos and Dixon, 1979; Sedlacek, 19801. Previous 
studies in our laboratory, using chemiluminescence as an indicator of membrane 
perturbation and/or phagocytosis, suggest that PMN exert anti-HSV activity in the 
presence of specific antibody, but the virus alone has no effect [Bingham et al, 19851. 
In an effort to clarify further the interactions between PMN and HSV in ocular 
infection, we studied the ability of PMN to mediate clearance of virus and virus- 
antibody complexes. The rabbit was used for our studies because the clinical disease 
in this model parallels the sequence of disease in human herpes keratitis [Meyers- 
Elliot et al, 19831. The parameters addressed were: (1) the permissiveness of PMN 
to HSV replication, (2) the ability of PMN to bind and ingest HSV, and (3) the ability 
of PMN to bind and phagocytize HSV-antibody complexes. 
MATERIALS AND METHODS 
Preparation of PMN 
Blood was collected from adult New Zealand white rabbits into a syringe 
containing heparin (20 units/ml blood). PMN were separated from whole blood by 
modification of the method described by Boyum [ 19681. Briefly, 10 ml of heparinized 
blood was diluted 1 :4 with Hanks balanced salt solution (HBSS), layered on a Ficoll- 
Hypaque gradient, and centrifuged for 40 min at 400 g. The resulting erythrocyte- 
PMN pellet was resuspended in 20 ml of autologous plasma and 8 ml of a 4.5% 
Dextran T-500 solution and incubated for 60 min at 37°C. 
Following incubation, the PMN-rich supernatant was collected and spun for 10 
min at 300 g. Residual erythrocytes were lysed with ACK buffer (30 mM NH4C1, 2 
mM KHC03, 0.02 mM disodium EDTA). PMN purity was greater than 95% as 
assessed by Wrights stain and PMN viability exceeded 90% as determined by trypan 
blue exclusion. 
Preparation of Virus 
The RE strain of HSV-1 was used. This strain was originally isolated from a 
human corneal lesion and has been used in studies of herpetic stromal disease in 
rabbits without a high incidence of mortality from encephalitis. It produces a spectrum 
of disease in rabbits comparable to that seen in humans [Irvine and Kimura, 1967; 
Metcalf et al, 1976; Wander et al, 19801. 
The RE strain was grown in SIRC (Staaten Serum Institut Rabbit Cornea) 
monolayers with minimal essential medium (MEM) and 5 % fetal calf serum (FCS) at 
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37°C. When cytopathological changes involved 100% of the monolayer, culture fluid 
from infected cells was clarified by two cycles of low speed centrifugation (500 g for 
15 min). The resulting supernatant was precipitated with polyethylene glycol (PEG) 
as described by Powell and Watson [I9751 to obtain an enriched population of 
enveloped virus. 
After an overnight incubation, the HSV precipitate was layered over a continu- 
ous 20-60% sucrose gradient and centrifuged at 85,000 g for 60 min. The virus band 
was collected, repelleted, rebanded on a sucrose gradient, and resuspended in MEM 
supplemented with 2% FCS and stored at -70°C. The PEG-purified HSV prepara- 
tion had a titer of 8 X lo7 plaque forming units (PFU)/ml in Vero cells. 
Virus Replication in PMN 
Peripheral blood PMN from normal rabbits were suspended in RPMI-1640 
medium with 20% rabbit serum and seeded into 24-well tissue culture plates (5 x lo5 
PMN/well). After 60 min at 37"C, PMN cultures were incubated with HSV until 
harvest or exposed to virus 2 hr, washed, and overlaid with fresh medium. Culture 
supernatants were harvested at various time intervals up to 96 hr. Fluids were clarified 
by centrifugation (500 g for 10 min) and quantitated for plaque forming units on Vero 
cell monolayers using 1 % agarose in MEM as the overlay medium. 
Virus Adsorption to PMN 
Both rabbit peripheral blood PMN and Vero cells were adjusted to a concentra- 
tion of 2 X lo6 cells/ml in RPMI-1640 supplemented with 10% rabbit serum. We 
added 0.5 ml of cells or medium alone to wells of a 24-well plastic tissue culture 
plate and mixed with 0.1 ml of HSV at 22°C. Virus was diluted to achieve input 
multiplicities of infection (MOI) of 10 and 1. At designated times after addition of 
virus (5, 15, 30, and 60 min) culture fluid was harvested, clarified by centrifugation 
(500 g for 10 min), and quantitated by plaque assay in Vero cells. 
Purification of IgG 
Antiserum to the RE strain of HSV-1 was produced in New Zealand white 
rabbits weighing 2-3 kg. Each eye was injected intrastromally with 0.02 ml of virus 
preparation containing lo6 PFU. 
At 28 days postinfection, animals were exsanguinated and the blood allowed to 
clot at room temperature. The serum was separated by one cycle of centrifugation 
and then heated for 30 min at 56°C to inactivate complement. 
IgG was precipitated from immune serum with a neutralization titer of 1024 by 
the addition of ammonium sulfate and then separated from other charged serum 
proteins by ion exchange chromatography on DEAE cellulose [Garvey et al, 19771. 
Peak protein fractions from the column were pooled and concentrated on a PM-10 
membrane (Amicon Corp., Lexington, MA). The protein content of purified IgG was 
determined by absorbance at 280 nm and purity analysis done by Ouchterlony 
immunodiffusion. 
Radiolabeling of Purified HSV and IgG 
Purified HSV was radiolabeled with '2510dine (New England Nuclear, Boston, 
MA) either by the lactoperoxidase method described by Fenger et a1 [ 19781 or through 
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metabolic incorporation of the amino acid 35S-methionine [Eberle and Courtney, 
19801. 
Purified IgG was radiolabeled by the chloramine-T method of McConahey and 
Dixon [ 19661 and by the lactoperoxidase technique of Marchalonis [ 19691, modified 
by Kozel and McGaw [ 19791. 
Preparation of Virus-Antibody Complexes 
Purified radioiodinated HSV (1.3 m g / d  protein) was combined in equal parts 
with either a 1 : 10 dilution of rabbit antiserum to HSV or commercial rabbit serum 
that showed no antibody to HSV. Following a 30-min incubation at 37"C, virus- 
antibody complexes and free virus were pelleted by centrifugation (85,000 g for 60 
min), washed twice with MEM plus 2% FCS, and stored at -70°C. Immune 
complexes containing 3'S-HSV were made, washed, and stored in a similar manner. 
Radioiodinated IgG (1 mg/ml) was prepared from rabbit antiserum to HSV and 
combined in equal volumes with purified virus. The mixture was incubated for 30 
min at 37°C in a shalung waterbath and then centrifuged at 1000 g for 30 min to 
sediment the insoluble complexes. The complexes were washed twice, resuspended 
in MEM plus 2% FCS, and stored at -70°C. 
Immune Complex Binding Assay 
The uptake of radiolabeled complexes by rabbit PMN was measured by a 
modification of the coverslip assay of Smith and Rommel [ 19771. In this assay system, 
12 mm round #1 thickness coverslips were cleaned with acetone and placed in 16 mm 
wells of a 24-well tissue culture plate. PMN in RPMI-1640 supplemented with 20% 
normal rabbit serum were seeded onto the coverslip (5 X 10' PMN/coverslip) and 
allowed to adhere for 1 hr at 37°C in a 5% C02  atmosphere. Control (blank) 
coverslips were treated with medium plus rabbit serum. Following incubation, each 
coverslip was washed with medium to elute nonadherent cells and serum components. 
We added 50 pl of radiolabeled complexes to each coverslip. After a 10-min 
incubation at 37"C, the coverslips were removed from wells, washed four times with 
medium, drained dry with a tissue, and inserted into a bio-vial (Beckman). Iodinated 
samples were counted on a Biogamma counter (Beckman) to quantitate coverslip 
associated radioactivity. Quantitation of 35S-radioactivity was accomplished by tissue 
solubilization and liquid scintillation spectrometry as described by Smith et a1 [ 19791. 
Electron Microscopy 
Complexes formed by combining PEG concentrated HSV and ammonium sul- 
fate precipitated IgG were incubated with rabbit PMN for 5 min at 37°C. In 
preparation for thin sectioning, PMN were washed twice with Tyrode's solution (pH 
7.2), fixed in 1% glutaraldehyde, postfixed in osmium tetroxide, dehydrated in 
ethanol, and embedded in epoxy resin (Araldite). Thin sections were stained with 
uranyl acetate and lead citrate (pH 7.0) and examined in a Phillips 201 electron 
microscope. 
RESULTS 
Permissiveness of Rabbit Peripheral Blood PMN to HSV Replication 
Studies were done to determine if the interaction between HSV and PMN results 
in viral replication. The findings in Figure 1 indicate that no detectable replication of 
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Fig. 1. Replication of HSV in PMN. PMN from peripheral blood of normal rabbits were allowed to 
adhere to bottoms of 24-well plastic tissue culture plates (5 x lo5 cells/well) before exposure to 
infectious virus (MOI of 100). Tissue culture fluid was harvested at various times after addition of virus. 
The titer of infectious HSV was determined by plaque assay under agarose on Vero cell monolayers. 
Results are expressed as the mean of triplicate cultures. Symbols: A medium + HSV; 0 PMN + HSV 
incubated for 2 hr at 37°C and washed to remove HSV inoculum; 0 PMN + HSV incubated together 
at 37°C. 
HSV occurs in rabbit PMN. Cultures exposed to infectious virus for 2 hr or longer 
showed no increase in virus yield. Slight decreases in virus titer were observed in all 
samples examined beyond 2 hr. Both PMN exposed to virus and that incubated with 
medium alone exhibited similar patterns of loss of infectivity. Electron microscopy 
revealed no evidence of permissive or abortive infection in PMN examined 24-48 hr 
after addition of HSV (data not shown). 
Binding of HSV to Rabbit Peripheral Blood PMN 
To determine if rabbit PMN bound or absorbed HSV, experiments were per- 
formed in which infectious virus was exposed to PMN in culture. Supernatant fluids 
were examined for virus at various time intervals. Results shown in Figure 2 indicate 
no adsorption or binding of HSV to PMN. Supernatant fluids contained the same 
amount of infectious virus before and after incubation with PMN for both MOI's 
examined, 10 and 1. Vero cell monolayers served as positive binding controls. 
Decreases in virus titer were observed in supernatants from Vero cells as early as 5 
min after exposure to HSV. 
Binding of HSV-Antibody Complexes to PMN Using Radiolabeled Virus 
Preparations 
In an effort to determine if virus-antibody complexes interact with PMN, 
experiments were performed in which enveloped HSV, either externally labeled with 
'''Iodine or metabolically labeled with 35S-methionine, was exposed to immune 
serum and the resulting complexes were assayed for binding. Results in Table I show 
that enveloped '251-HSV incubated with normal rabbit serum was bound to PMN at 
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Fig. 2. Binding of HSV to PMN. Infectious HSV was added to suspensions of either 2 X lo6 rabbit 
PMN or 2 x lo6 Vero cells at MOI's of 10 and 1. The cultures were continuously agitated and at 
designated time intervals aliquots were collected. Culture fluids were clarified of cells by centrifugation 
at 500 fig and screened for reduction in HSV titer by plaque assay under agarose on Vero cells. Results 
are expressed as mean values of triplicate samples. MOI of 10: A medium + HSV; 0 PMN + HSV; 
Vero + HSV. MOI of 1: A medium + HSV; 0 PMN + HSV; 0 Vero + HSV. 
TABLE I. Binding of Virus-Antibody Complexes to PMN 
Using Radiolabeled HSV Preparations 
Reaction mixture Activity 
Cells ComDlex (CPMY 
None Iz5I-HSV + NRSb 980 + 82 
None Iz5I-HSV + Ab 1446 k 162 
PMN IZ5I-HSV + NRS 4591 + 171 
PMN Iz5I-HSV + Ab 14942 k 1001 
None 35S-HSV + NRS 105 k 10 
None 35S-HSV + Ab 602 + 54 
PMN 35S-HSV + NRS 2750 244 
PMN 35S-HSV + Ab 6516 f 595 
aResults represent the mean of sextuplicate coverslips + SEM. 
bNRS, normal rabbit serum. 
greater than fourfold the amount of activity associated with control coverslips. 
Addition of complexes of '251-HSV and HSV specific antibody produced activity 
tenfold greater than blank coverslips and threefold greater than that associated with 
PMN and virus exposed to nonimmune serum. 
The same pattern of response was seen when 35S-HSV was substituted for 1251- 
HSV in immune complexes. Approximately the same ratios of activity were observed. 
Immune complexes formed using 35S-HSV antibody demonstrated the highest activity 
associated with PMN. 
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Binding of Virus-Antibody Complexes to PMN Using Radiolabeled 
Anti-HSV IgG 
The results of experiments using complexes comprised of '251-IgG and HSV to 
demonstrate binding to PMN are shown in Table 11. With nonspecific binding controls 
( '251-IgG and supernatant from uninfected SIRC cells), no increase in '251-IgG activity 
associated with PMN was detected above background binding levels. However, when 
complexes of '251-IgG and unlabeled HSV were combined with PMN, a tenfold 
increase in activity was observed. 
Effect of Complement on the Binding of Virus-Antibody Complexes to PMN 
To examine the effect of complement, experiments were performed in which 
either heat inactivated or native guinea pig complement was added to immune 
complexes. Incubation of immune complexes with native guinea pig complement 
produced an approximate twofold increase in activity bound to PMN over complexes 
incubated with heat inactivated complement (Table 111). Controls showed an approxi- 
mate fourfold increase in activity of 1251-HSV and antibody complexes associated 
with PMN compared to background coverslips. 
Internalization of HSV-Antibody Complexes by PMN 
To determine whether the interactions between PMN and HSV-antibody com- 
plexes resulted in internalization by phagocytosis, we performed experiments utilizing 
TABLE 11. Binding of Virus-Antibody Complexes to PMN 
Using Radiolabeled Anti-HSV IgG 
Reaction mixture Activity 
Cells Comolex (CPM)a 
None 1251-IgG + mediumb 274 k 14 
None "'I-IgG + HSVC 339 +_ 61 
PMN Iz5I-IgG + medium 342 k 9 
PMN Iz5I-IgG + HSV 3419 f 286 
aResults represent the mean of triplicate coverslips k SEM. 
bAntibody incubated with supernatant from uninfected SIRC 
cultures (30 min at 37°C) and pelleted by ultracentrifugation 
(85,000 g for 60 min). 
'Insoluble immune complexes pelleted by low speed 
centrifugation (1,OOO g for 30 min) and washed prior to use. 
TABLE 111. Effect of Complement on the Binding of 
Virus-Antibodv Comolexes to PMN 
Activity 
Cells Comulex (CPM\a 
Reaction mixture 
None 1251-HSV + Ab + ACb 684 f 101 
PMN I2%HSV + Ab + AC 2850 k 230 
PMN IZ5I-HSV + Ab + C 4492 k 304 
aResults represent the mean of quadruplicate coverslips & 
SEM. 
bComplexes incubated for 30 min at 37°C with an equal volume 
of a 1 : 10 dilution of heat-inactivated guinea pig complement. 
'Complexes incubated for 30 min at 37°C with an equal volume 
of a 1 : 10 dilution of guinea pig complement. 
None 1251-HSV + Ab + Cc 1166 +_ 95 
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electron microscopy. Figure 3 shows the results of incubating virus-antibody com- 
plexes with PMN. Enveloped HSV can clearly be seen within phagocytic vacuoles 
and attached to the PMN cytoplasmic membrane. Experiments using HSV incubated 
either alone or after exposure to nonimmune serum resulted in no visible internaliza- 
tion of virions (data not shown). 
Fig. 3. Internalization of HSV-antibody complexes by PMN. The arrows denote complete enveloped 
HSV particles that are attached to the cytoplasmic membrane and internalized within the phagocytic 
vacuoles of rabbit PMN. Photograph was taken 5 min after addition of virus-antibody complexes to 
PMN. Magnification, X36,OOO. 
Binding of HSV-Ab Complexes by HSV 159 
DISCUSSION 
Herpetic stromal keratitis causes corneal damage that may result in blindness. 
At present, it is not clear whether PMN induce, mediate, or contribute to the 
pathogenesis of the disease in vivo. 
Enhancement of HSV virulence may result from the ability of the virus to infect, 
replicate, and persist in phagocytic cells. Peritoneal exudate macrophages from strains 
of mice susceptible to HSV infection in vivo have been shown to support the 
replication of HSV [Brucher et al, 19841. It has also been shown that HSV [Daniels 
et al, 19781, rubella [Van Deg Logt, 19801, and dengue-2 [Brandt et al, 19791 viruses 
are capable of replicating in human monocytes and macrophages. Our laboratory has 
reported HSV permissiveness following mitogenic stimulation of human lymphocytes 
[Plaeger-Marshall and Smith, 19781. In addition, we have demonstrated limited 
permissiveness of rabbit macrophages to HSV infection [Plaeger-Marshall et al, 
19811. Rabbit monocytes, on the other hand, showed no detectable interaction with 
virus. In addition to in vitro studies, fluorescent antibody probes have suggested the 
presence of HSV or HSV antigens within PMN from infiltrates associated with 
herpetic keratitis [Meyers and Pettit, 1973; Meyers-Elliot et al, 1980; Meyers-Elliot 
and Chitjian, 19811. 
In the present study of HSV-PMN interactions, no replication or adsorption of 
HSV to PMN was observed. Regarding replication, no increase in virus titer was 
seen in PMN exposed to HSV. Samples of PMN taken 2 4 4 8  hr after exposure to 
HSV and examined by electron microscopy showed no evidence of complete virions 
or abortive infection. Binding experiments using PMN mixed with HSV at two MOI’s 
revealed no measurable adsorption, whereas Vero cell controls gave positive binding 
results under the same conditions. The data presented suggest that rabbit PMN do not 
recognize HSV by itself, supporting results from studies in this laboratory using 
chemiluminescence as an assay system [Bingham et al, 19851. Explanations for PMN 
nonpermissiveness could be the phagocyte’s lack of receptors, short life span, and 
limited capacity for protein synthesis, all of which my reflect differences in degrees 
of cellular maturation and differentiation. 
It has been well established that PMN ingest and kill bacteria and fungi [Hilger 
and Danley, 1980; Klebanoff, 1975; Schuit, 19791. In antiviral defense, PMN are 
presumed to be active in the clearance of virus-antibody complexes through phago- 
cytosis following recognition by receptors that bind to antibody and complement 
[Allison, 19741. Opsonins, such as IgG, interact with the material to be phagocytized, 
adding a host protein coating that facilitates internalization via the PMN Fc receptor 
[Eden et al, 1973; Phillips-Quagliata et al, 1969; Theofilopoulos et al, 1974; Wiggins 
and Cochrane, 19811. 
A variety of techniques have been employed to quantitate phagocytosis by PMN. 
Some methods determine the number of particles removed from the culture medium; 
others count the number of particles that appear within phagocytes. The uptake of 
radioactive protein from the suspending medium is another approach to measuring 
phagocytosis [Chang, 19691. Using this last approach, Ward and Zvaifler [ 19731 
described a method for the quantitative measurement of phagocytosis by neutrophils 
using radiolabeled immune complexes. Because of particle size, virus uptake by cells 
cannot be visually assessed by light microscopy. Therefore, the ability to assay 
phagocytosis with labeled immune complexes becomes a particularly useful tool when 
studying the interactions between PMN and viruses. 
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In our current study using radiolabeled complexes, we have demonstrated that 
HSV-antibody complexes bind to PMN. We employed complexes containing either 
'251-HSV, 35S-HSV, or 1251-IgG and obtained similar patterns of response, thus 
minimizing the chance that the results observed were an artifact of assay conditions. 
Increased binding occurred using HSV labeled externally with 12510dine or metaboli- 
cally with 35S-methionine for the formation of antigen-antibody complexes. When 
radiolabeled antibody (1251-IgG anti-HSV) was combined with virus in immune 
complexes, there was a dramatic increase in the binding activity to PMN in contrast 
to the low activity produced by unaggregated 12510dine labeled HSV-IgG controls. In 
an unrelated study, using similar procedures, Shinomaya and Koyama [ 19761 found 
that '251-IgG alone bound minimally to guinea pig macrophages whereas '251-IgG 
combined with hapten was rapidly bound and internalized. 
The addition of complement to virus-antibody complexes is presumed to en- 
hance neutralization and immune clearance through enlargement of viral aggregates. 
Studies have shown that immune complexes containing complement bind to phago- 
cytes with greater affinity than those without complement [Kijlstra et al, 1979; 
Mantovani et al, 1972; Van Snick and Masson, 19781. Our data support the concept 
that complement increases binding of immune complexes to PMN. The addition of 
active complement to radiolabeled complexes was found to increase activity associ- 
ated with PMN by as much as 25 % . 
The data presented clearly demonstrate that PMN bind HSV-antibody com- 
plexes and that the binding activity increases with the addition of complement. To 
determine whether ingestion as well as adsorption of immune complexes occurs, we 
employed electron microscopy. This approach resulted in direct visualization of 
internalized HSV-antibody complexes. Enveloped virions were observed both within 
phagocytic vacuoles and adherent to the PMN cytoplasmic membrane. 
In the initial stages of acute inflammation large numbers of PMN are recruited 
to destroy and remove the inflammatory stimuli via phagocytosis [Issekutz et al, 
19811. The presence of PMN in the corneal stroma during HSV keratitis can be 
explained by the liberation of proteases from damaged cells, the activation of the 
complement cascade by antigen-antibody complexes, the release of leukotactic factors 
by virus-sensitized lymphocytes, and the chemotactic properties of collagenase in the 
cornea [Meyers and Pettit, 19741. 
Gradually, macrophages accumulate at the same locations for further removal 
of inflammatory stimuli. Macrophages also initiate tissue repair and immunological 
responses such as antigen presentation to T lymphocytes. Phagocytic cells at the sites 
of inflammation bind or ingest immune complexes formed during the course of the 
disease. Occasionally the removal of such complexes is not efficiently achieved 
resulting in the subsequent synthesis and release of more inflammatory mediators by 
PMN and macrophages [Davies and Bonney, 19811. 
The pathogenesis of herpetic stromal keratitis remains unclear. It is not fully 
understood how much of the disease process is due to viral replication and how much 
is due to the immune response to viral antigens. Our observations that PMN are 
capable of binding and ingesting HSV-antibody complexes suggest that PMN play a 
beneficial role in the clearance of virus during herpetic keratitis. 
Previous reports [Dawson and Togni, 1976; Pettit and Meyers-Elliot, 19731 
have suggested a major role for specifically sensitized lymphocytes in chronic recur- 
rent corneal inflammation. Our data do not exclude such a possibility. It is clear that 
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a combination of inflammatory cells are active during the course of herpetic keratitis 
and that a complete understanding of their interrelationships and mechanisms involved 
in immune destruction will require further investigation. 
ACKNOWLEDGMENTS 
This work was supported by Public Health Service grant EY05105 from the 
National Eye Institute. 
REFERENCES 
Allison AC (1974): Interaction of antibody, complement, and various cell types in immunity against 
viruses and pyogenic bacteria. Transplantation Review 19:3-55. 
Bingham EL, Fenger TW, Sugar A, Smith JW (1985): Dependence on antibody for induction of 
chemiluminescence in polymorphonuclear leukocytes by herpes simplex virus. Investigative 
Ophthalmology and Visual Science 26: 1236-1243. 
Boyum A (1968): Isolation of mononuclear cells and granulocytes from human blood. Scandinavian 
Journal of Clinical Laboratory Investigation 21 :77-89. 
Brandt WE, McCown JM, Top FH, Bancroft WH, Russell PK (1979): Effect of passage history on 
dengue-2 virus replication in subpopulations of human leukocytes. Infection and Immunity 
Brucher J, Domke I, Schroder CH, Kirchner H (1984): Experimental infection of inbred mice with 
herpes simplex virus. Archives of Virology 82:83-93. 
Chang Y (1969): Studies on phagocytosis. I. Uptake of radioiodinated (I3’I) human serum albumin as a 
measure of the degree of phagocytosis in vitro. Experimental Cell Research 54:42-48. 
Daniels CA, Kleinerman ES, Snyderman R (1978): Abortive and productive infections of human 
mononuclear phagocytes by type 1 herpes simplex virus. American Journal of Pathology 91: 
119- 136. 
Davies P, Bonney RJ (1981): Some basic mechanisms of inflammatory responses. In Suran A, Gery I, 
Nussenblatt RB (eds): “Immunology of the Eye; Workshop 111. ” Arlington, VA: Information 
Retrieval Inc., pp 273-290. 
Dawson CR. Togni B (1976): Herpes simplex eye infections: Clinical manifestations, pathogenesis and 
management. Survey of Ophthalmology 21: 121-135. 
Eberle R, Courtney RJ (1980): Preparation and characterization of specific antisera to individual antigens 
comprising the major glycoprotein region of herpes simplex virus type 1. Journal of Virology 
Eden A, Bianco C,  Nussenzweig V (1973): Mechanisms of binding soluble immune complexes to 
lymphocytes. Cellular Immunology 7:459-473. 
Faden H, Hong JJ, Ogra PL (1983): Activation of oxidative and arachidonic acid metabolism in 
neutrophils by respiratory syncytial virus antibody complexes: Possible role in disease. Journal 
of Infectious Disease 148: 110-116. 
Feigin RD, Shakelford PG (1973): Value of repeat lumbar puncture in differential diagnosis of menin- 
gitis. New England Journal of Medicine 289 
Fenger TW, Smith JW, Howe C (1978): Analysis of ecipitated surface glycoproteins in measles 
virions and in membranes of infected cells. Journal of Virology 28:292-299. 
Garvey JS, Cremer NS, Sussdorf DH (eds) (1977): Ammonium sulfate precipitation. In “Methods in 
Immunology.” Reading, MA: WA Benjamin Inc., pp 218-219. 
Garvey IS, Cremer NS, Sussdorf DH (eds) (1977): DEAE cellulose chromatography. In “Methods in 
Immunology.” Reading, MA: WA Benjamin Inc., pp 222-226. 
Hilger AE, Danley DL (1980): Alteration of polymorphonuclear leukocyte activity by viable Candida 
albicans. Infection and Immunity 27:714-720. 
Irvinc AR, Kimura SJ (1967): Experimental stromal herpes simplex keratitis in rabbits. Archives of 
Ophthalmology 78:654-663. 
Issekutz TB, Issekutz AC, Movat HZ (1981): The in-vitro quantitation and kinetics of monocyte 
migration into acute inflammatory tissue. American Journal of Pathology 103:47-55. 
26:534-541. 
35:902-9 17. 
162 Smith, Jachimowicz, and Bingham 
Kaul TN, Faden H, Ogra PL (1981): Effect of respiratory syncytial virus and virus-antibody complexes 
on the oxidative metabolism of human neutrophils. Infection and Immunity 32:649-654. 
Kijlstra A, Vanes LA, Daha MR (1979): The role of complement in the binding and degradation of 
immunoglobulin aggregates by macrophages. Journal of Immunology 123:2488-2493. 
Klebanoff SJ (1975): Antimicrobial systems of the polymorphonuclear leukocyte. In Dayton DH (ed): 
“The Phagocytic Cell in Host Resistance.” New York: Raven Press, pp 45-59. 
Kozel TR, McGaw TG (1979): Opsonization of Cryptococcus neoformans by human IgG: Role of IgG 
in phagocytosis by macrophages. Infection and Immunity 25:255-261. 
Mantovani B, Rabinovitch M, Nussenzweig V (1972): Phagocytosis on immune complexes by macro- 
phages, different roles for the macrophage receptor sites for complement and IgG. Journal of 
Experimental Medicine 135:780-792. 
Marchalonis JJ (1969): An enzymatic method for trace iodination of immunoglobulins and other proteins. 
Biochemistry Journal 113:299-305. 
McConahey PJ, Dixon FJ (1966): A method of trace iodination of proteins for immunologic studies. 
International Archives of Allergy 24: 185-189. 
Metcalf JF, McNeill JI, Kaufman HE (1976): Experimental disciform edema and necrotizing keratitis in 
the rabbit. Investigative Ophthalmology 15:979-985. 
Metcalf JF, Reichert RW (1979): Histological and electron microscopic studies of experimental herpetic 
keratitis in the rabbit. Investigative Ophthalmology 18: 1123-1138. 
Meyers RL, Pettit TH (1973): The pathogenesis of corneal inflammation due to herpes simplex virus. I. 
Corneal hypersensitivity in the rabbit. Journal of Immunology 111: 1031-1042. 
Meyers RL, Pettit TH (1974): Chemotaxis of polymorphonuclear leukocytes in corneal inflammation: 
Tissue injury in herpes virus infection. Investigative Ophthalmology 13: 187-197. 
Meyers-Elliot RH, Pettit TH, Maxwell WA (1980): Viral antigens in the immune ring of herpes simplex 
stromal keratitis. American Journal of Ophthalmology 89: 897-904. 
Meyers-Elliot RH, Chitjian PA (1981): Immunopathogenesis of corneal inflammation in herpes simplex 
stromal keratitis: Role of the polymorphonuclear leukocyte. Investigative Ophthalmology and 
Visual Science 20:784-798. 
Meyers-Elliot RH, Chitjian PA, Dethlefs BA (1983): Experimental herpes virus keratitis in the rabbit: 
Topical versus intrastromal infection routes. Ophthalmic Research 15:240-256. 
Notkins AL, Mergenhagen S, Howard R (1970): Effects of virus infections on the functions of the 
immune response. Annual Review of Microbiology 24:525-538. 
Phillips-Quagliata JM, Levine BB, Uhr JW (1969): Studies on the mechanisms of binding immune 
complexes to phagocytes. Nature 222: 1290-1291. 
Plaeger-Marshall S, Smith JW ( 1978): Experimental infection of subpopulations of human peripheral 
blood leuckocytes by herpes simplex virus. Proceedings of the Society for Experimental Biology 
and Medicine 158:263-268. 
Plaeger-Marshall S, Wilson LA, Smith JW (1981): Permissiveness of rabbit monocytes and macrophages 
for herpes simplex virus type 1. Infection and Immunity 35:151-156. 
Powell KL, Watson DH (1975): Some structural antigens of herpes simplex virus. Journal of General 
Virology 29: 167-178. 
Schuit K (1979): Phagocytosis and intracellular killing of pathogenic yeasts by human monocytes and 
neutrophils. Infection and Immunity 24:932-938. 
Sedlacek HH (1980): Pathophysiological aspects of immune complex disease. Klinische Wochenschrift 
Shinomiya T, Koyama J (1976): In vitro uptake and digestion of immune complexes containing guinea 
pig IgGl and IgG2 antibodies by macrophages. Immunology 30:267-275. 
Smith DL, Rommel F (1977): A rapid micro method for the simultaneous determination of phagocyte- 
microbicidal activity of human peripheral blood leukocytes in vitro. Journal of Immunological 
Methods 17:241-247. 
Smith JW, Torres JE, Holmquist ND (1979): Association of herpes simplex virus (HSV) with cervical 
cancer by lymphocyte reactivity with HSV-1 and HSV-2 antigens. American Journal of Epide- 
miology 110: 141-147. 
Stevens DA, Ferrington RA, Jordan GW, Merigan TC (1975): Cellular events in zoster vesicles: Relation 
to clinical course and immune parameters. Journal of Infectious Diseases 131 :509-514. 
Theofilopoulos AN, Dixon FJ, Boksich VA (1974): Binding of soluble immune complexes to human 
lymphoblastoid cells. I. Characterization of the receptors for IgG, Fc, and complement and 
description of the binding mechanisms. Journal of Experimental Medicine 140:877-894. 
58593-605. 
Binding of HSV-Ab Complexes by HSV 163 
Theofilopoulos AN, Dixon FJ (1979): The biology and detection of immune complexes. Advances in 
Immunology 28: 89-220. 
Van Deg Logt JTM, Van Loon AM, Van Der Veen J (1980): Replication of rubella virus in human 
mononuclear blood cells. Infection and Immunity 27:309-3 14. 
Van Snick J, Masson PL (1978): The effect of complement on the ingestion of soluble antigen-antibody 
complexes and IgM aggregates by mouse peritoneal macrophages. Journal of Experimental 
Medicine 148:903-914. 
Wander AH, Centifanto YM, Kaufman HE (1980): Strain specificity of clinical isolates of herpes 
simplex virus. Archives of Ophthalmology 98: 1458-1461. 
Ward PA, Zvaifler NJ (1973): Quantitative phagocytosis by neutrophils. I. A new method with immune 
complexes. Journal of Immunology 111:1771-1776. 
Wiggins RC, Cochrane GC (1981) Immune complex mediated biologic effects. New England Journal of 
Medicine 304518-520. 
